Date published: 2025-12-19

1-800-457-3801

SCBT Portrait Logo
Seach Input

GOLGA6L1 Inhibitors

GOLGA6L1 inhibitors are chemical compounds that specifically target and modulate the activity of the GOLGA6L1 protein, a member of the Golgin family. The Golgins are a group of coiled-coil proteins primarily associated with the Golgi apparatus, an organelle responsible for processing and trafficking proteins and lipids within the cell. GOLGA6L1, like other Golgins, plays a role in maintaining the structural integrity of the Golgi and is involved in vesicle tethering and transport between the Golgi and other cellular compartments. Inhibition of GOLGA6L1 disrupts these processes, leading to alterations in Golgi morphology and function, which can affect cellular trafficking pathways. Such disruptions may cause a cascade of intracellular changes, influencing protein glycosylation, secretion, and the overall organization of the endomembrane system.

These inhibitors are typically designed with high specificity to interfere with the normal interactions of GOLGA6L1, potentially targeting its binding sites or altering its conformational state. As a result, these compounds provide a valuable tool for studying Golgi-related processes at the molecular level. By selectively inhibiting GOLGA6L1, researchers can gain insights into the broader regulatory mechanisms governing intracellular trafficking, Golgi structure, and protein sorting. Additionally, GOLGA6L1 inhibitors can help elucidate the protein's role in cellular homeostasis and the response to environmental stressors, such as oxidative damage or nutrient deprivation, contributing to a deeper understanding of Golgi dynamics and function.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Monastrol

254753-54-3sc-202710
sc-202710A
1 mg
5 mg
$120.00
$233.00
10
(1)

Monastrol inhibits the motor protein Eg5, which is essential for mitotic spindle formation. As Golgin subfamily A member 6-like protein 1 is involved in Golgi apparatus structure and function, inhibiting spindle formation disrupts the Golgi apparatus, leading to a functional inhibition of Golgin subfamily A member 6-like protein 1 due to its reliance on an intact Golgi structure for proper functioning.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$30.00
$52.00
$122.00
$367.00
25
(3)

Brefeldin A disrupts Golgi structure by inhibiting ADP-ribosylation factor, a small GTPase involved in vesicle trafficking. As Golgin subfamily A member 6-like protein 1 is associated with the Golgi apparatus, this disruption leads to direct functional inhibition of Golgin subfamily A member 6-like protein 1 by compromising its structural integrity and localization.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$87.00
44
(2)

Dynasore inhibits dynamin, a GTPase responsible for endocytosis and vesicle trafficking. By inhibiting dynamin, Golgin subfamily A member 6-like protein 1 is functionally inhibited as its role in vesicle tethering and trafficking at the Golgi is compromised due to the blockade of vesicle scission and release.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$58.00
$83.00
$140.00
$242.00
38
(2)

Nocodazole disrupts microtubule polymerization, which is vital for Golgi apparatus positioning and function. The functional inhibition of Golgin subfamily A member 6-like protein 1 occurs as a result of impaired microtubule-dependent Golgi organization, which is essential for its activity.

Golgicide A

1005036-73-6sc-215103
sc-215103A
5 mg
25 mg
$187.00
$670.00
11
(1)

Golgicide A is a specific inhibitor of Golgi BFA resistance factor 1 (GBF1), a GEF for ARF1 GTPase. Inhibition of GBF1 disrupts ARF1-mediated recruitment of coatomer proteins, leading to functional inhibition of Golgin subfamily A member 6-like protein 1 by interfering with its Golgi localization and membrane association.

Latrunculin B

76343-94-7sc-203318
1 mg
$229.00
29
(1)

Latrunculin B binds to actin monomers and prevents their polymerization. As actin dynamics are crucial for the maintenance of Golgi structure, the disruption of actin filaments leads to a functional inhibition of Golgin subfamily A member 6-like protein 1 by altering Golgi architecture and its associated functions.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$169.00
$299.00
66
(3)

Tunicamycin inhibits N-linked glycosylation, a process occurring in the Golgi. By inhibiting this process, Golgin subfamily A member 6-like protein 1 is functionally inhibited due to the reliance on proper glycosylation for its stability and function within the Golgi apparatus.

Jasplakinolide

102396-24-7sc-202191
sc-202191A
50 µg
100 µg
$180.00
$299.00
59
(1)

Jasplakinolide stabilizes actin filaments and prevents their disassembly. This alteration of actin dynamics can lead to a functional inhibition of Golgin subfamily A member 6-like protein 1 by disrupting the actin-dependent maintenance of Golgi structure and function.

Taxol

33069-62-4sc-201439D
sc-201439
sc-201439A
sc-201439E
sc-201439B
sc-201439C
1 mg
5 mg
25 mg
100 mg
250 mg
1 g
$40.00
$73.00
$217.00
$242.00
$724.00
$1196.00
39
(2)

Paclitaxel stabilizes microtubules and prevents their disassembly. As Golgin subfamily A member 6-like protein 1 requires dynamic microtubules for its proper function within the Golgi, the stabilization of microtubules can lead to its functional inhibition by altering normal microtubule-dependent processes.

Colchicine

64-86-8sc-203005
sc-203005A
sc-203005B
sc-203005C
sc-203005D
sc-203005E
1 g
5 g
50 g
100 g
500 g
1 kg
$98.00
$315.00
$2244.00
$4396.00
$17850.00
$34068.00
3
(2)

Colchicine binds to tubulin and inhibits its polymerization into microtubules. The resulting disruption in microtubule dynamics functionally inhibits Golgin subfamily A member 6-like protein 1 by compromising microtubule-dependent Golgi organization and trafficking.